Although most of the studies in the literature have focused on inactivating osteoclasts to treat osteoporosis, the aim of this study was to develop an ultrasound-responsive nanobubble that can deliver CTSK siRNA and CeNPs to suppress osteoclast differentiation and promote osteogenesis in vitro synergistically. This evidence concerns the gene CTSK and osteoporosis.